Ipca Laboratories
IPCALAB · Pharma > Pharmaceuticals & Drugs · Chairman: Premchand Godha · MD: Premchand Godha · Listing date: Oct. 24, 1994 · Employees: 14574 · Mumbai · http://www.ipca.com

Stock Price vs Company Growth
1d
1.4%
1w
5.2%
1m
17.5%
3m
32.9%
6m
61.3%
1y
33.0%
5y
24.1%
10y
13.6%
all
20.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

1,148 1.4%
868
1,153
Company Overview

Sales
6,679 Cr
Growth: 6.0%
Profit after Tax
492 Cr
Growth: 0.2%
Mid Cap
29,138 Cr
P/E: 59.2x
Industry P/E: 31.7x
Fundamentals

Sales (Cr) ₹ 6,679
Growth 6.0%
EBITDA 15.4%
P/S 4.4x
Dividend 0.5%
P/E 59.2x
Book Value ₹ 242
PEG Ratio 9.9x
ROE 8.3%
P/B 4.7x
Shareholding Pattern

Institutions
Dsp Midcap Fund
4.58 %
Hdfc Trustee Company Ltd - A/C Hdfc Mid - Capopportunities Fund
3.1 %
L And T Mutual Fund Trustee Ltd-L And T Mid Cap Fund
2.32 %
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund
2.19 %
Hdfc Life Insurance Company Limited
2.02 %
Promoters
Kaygee Investments Pvt. Ltd.
21.47 %
Kaygee Laboratories Pvt. Ltd.
6.61 %
Chandurkar Investments Pvt. Ltd.
5.5 %
Paschim Chemicals Pvt. Ltd.
4.0 %
Premchand Godha
2.29 %
Others
Iepf
0.29 %
Llp
0.02 %
Increase    Decrease    No change
Company Profile Detailed

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Services and productsAPI- Ipca produces various APIs at its production facilities. Its core strategic focus has been on backward integration, resulting in superior supply chain reliability and cost competitiveness in a dynamic market. Ipca has also emerged as one of India’s top exporters of APIs, serving in many countries around the globe.
Investors (98)
Followers (10)